Drug Discovery Biology
Other research themes
See the latest news
World first: Researchers from Monash University have harnessed cutting-edge technology to fill key gaps in our understanding of how promising new therapeutics could work for the treatment of obesity.
Monash University, together with principal partners The University of Melbourne, University of Wollongong, WEHI, today launched the Australian Research Council’s Industrial Transformation Training Centre for Cryo-electron Microscopy of
Two researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) are amongst the co-founders of an exciting new biotechnology company dedicated to discovering and advancing novel small molecule medicines targeting G protein-coupled
Monash University scientists have discovered the structure of the protein behind neurofibromatosis type 1 (NF1), a common genetic condition that causes tumours to form on nerve tissue.
Professor Arthur Christopoulos, Professor Patrick Sexton and Associate Professor Denise Wootten are amongst the world’s most influential researchers, according to the 2021 iteration of the Clarivate Analytics Highly Cited Researchers list.
Monash University today will launch an end-to-end, cross-disciplinary Centre to drive novel psychiatric drug discovery, as well as new approaches to neuromedicine-assisted psychotherapies, for the treatment of mental health disorders.
Funding through the Commonwealth Government’s National Health and Medical Research Council (NHMRC) has been announced, with the Monash Institute of Pharmaceutical Sciences (MIPS) successful in grants totalling close to $3.5 million.
Monash University researcher and collaborator in the US published a review summarising recent studies on fructose and how high consumption of fructose leads to certain “lifestyle diseases”.
Monash University researchers have made a breakthrough discovery that could pave the way for the development of novel non-opioid painkillers (analgesics) to safely and effectively treat neuropathic pain.